MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Josiah A Peter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, U.S.A. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Rett Syndrome, DNA, RNA. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Rett syndrome neurodevelopmental disorder is caused by mutations in the epigenetic regulator MeCP2. While the MeCP2 methyl-CpG binding domain (MBD) is well-characterized, the function of the adjacent intervening domain (ID) remains largely understudied. The ID has been described as a distinct RNA-binding region, yet evidence also suggests RNA competitively displaces MeCP2 from DNA. Here, we address these conflicting findings by demonstrating the MBD and ID do not function in isolation but as a synergistic functional unit. The ID significantly enhances affinity of the MBD for methylated DNA by ∼35-fold. Moreover, these two subdomains form a high-affinity RNA-binding module, with preference for structured RNAs increased over 1000-fold compared to the MBD or ID alone. We find binding to RNA precludes binding to DNA, such that the integrated MBD-ID unit explains the competition phenomenon. Analysis of Rett syndrome-associated ID mutations (R167W, K174Q, and R190H) and a therapeutic MiniGene reveals they do not disrupt methyl-DNA binding but instead selectively weaken RNA and non-methylated DNA binding, thereby disrupting the competitive balance between nucleic acids. Our work establishes the MBD-ID module as MeCP2’s central nucleic acid interaction hub, whose disruption provides a potential molecular etiology of Rett syndrome due to mutations in the ID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, U.S.A.
- Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80309, USA.
ORCID-Profile: Josiah A Peter, Thomas A Weiser, Lee A Niswander, Robert T Batey, Deborah S Wuttke
Förderung
- NCRR NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- Innovation Award from the International Rett Syndrome Foundation
- The Shurl and Kay Curci Foundation
- NIH
Zitieren
APA
Peter, J. A., Weiser, T. A., Niswander, L. A., Batey, R. T., & Wuttke, D. S. (2026). MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag890
Vancouver
Peter JA, Weiser TA, Niswander LA, Batey RT, Wuttke DS. MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag890
BibTeX
@article{Peter2026,
author = {Peter, Josiah A and Weiser, Thomas A and Niswander, Lee A and Batey, Robert T and Wuttke, Deborah S},
title = {MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag890}
}
EUVIMED